At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer.
Every day we see the impact that our treatments offer and the potential they have to provide a world beyond cancer and other debilitating conditions. We continue to push boundaries and reach new heights in everything we do, supported by significant investment into new technologies and therapies.
The name ‘Curium’ honors the legacy of pioneering radioactive researchers Marie and Pierre Curie, after whom the radioactive element curium was named. Today, we build on their legacy with our life-saving diagnostics, reaching over 14 million patients every year. We use our unparalleled expertise to explore the untapped potential of nuclear medicine, providing quality products, quality of care and quality of life. We strive to transform each life we touch.
To learn more, visit www.curiumpharma.com